Successful unrelated bone marrow transplantation in two siblings with alpha-mannosidosis.

Abstract

Alpha-mannosidosis is a rare lysosomal storage disorder with an autosomal recessive inheritance. Deficient alpha-mannosidase activity leads to lysosomal accumulation of mannose-rich oligosaccharides. The disease characterized by mental retardation, skeletal changes, hearing impairment, and recurrent infections. Stem cell transplantation has been shown to be an effective treatment. It works by providing increased levels of α-mannosidase in the localized extracellular milieu to provide improvements in skeletal malformations, neurocognitive, and sensorineural function. In this case report, we describe a pair of siblings with α-mannosidosis who successfully underwent HSCT from matched unrelated donors. In both siblings, enzyme levels reached to normal limits and improvements in clinical symptoms were recognized early after HSCT. We conclude that HSCT should be considered as a therapeutic approach in patients with alpha-mannosidosis before disease-related complications have developed.

• Authors: Akif M Yesilipek, Mediha Akcan, Gulsun Karasu, Vedat Uygun, Alphan Kupesiz, Volkan Hazar
• Journal: Pediatric transplantation (Pediatr Transplant) Vol. 16 Issue 7 Pg. 779-82 (Nov 2012) ISSN: 1399-3046 [Electronic] Denmark
• PMID: 22775975 (Publication Type: Case Reports, Journal Article)
• Copyright: © 2012 John Wiley & Sons A/S.

Chemical References

• Oligosaccharides

Topics

• Bone Marrow Transplantation (methods)
• Child
• Female
• Humans
• Male
• Oligosaccharides (chemistry)
• Recurrence
• Siblings
• Stem Cells (cytology)
• Transplantation, Homologous (methods)
• Treatment Outcome
• alpha-Mannosidosis (therapy)